These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 8382801)

  • 21. [Quantitative analysis of DNA topoisomerase I activity in human and rat glioma: characterization and mechanism of resistance to antitopoisomerase chemical, camptothecin-11].
    Matsumoto Y; Fujiwara T; Honjo Y; Sasaoka N; Tsuchida T; Nagao S
    Noshuyo Byori; 1994; 11(1):59-64. PubMed ID: 8162152
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin.
    Jaxel C; Capranico G; Kerrigan D; Kohn KW; Pommier Y
    J Biol Chem; 1991 Oct; 266(30):20418-23. PubMed ID: 1657924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Escherichia coli topoisomerase III-catalyzed cleavage of RNA.
    DiGate RJ; Marians KJ
    J Biol Chem; 1992 Oct; 267(29):20532-5. PubMed ID: 1383203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DNA sequence selectivity of human topoisomerase I-mediated DNA cleavage induced by camptothecin.
    Punchihewa C; Carver M; Yang D
    Protein Sci; 2009 Jun; 18(6):1326-31. PubMed ID: 19472416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of topoisomerase I as the cytotoxic target of the protoberberine alkaloid coralyne.
    Gatto B; Sanders MM; Yu C; Wu HY; Makhey D; LaVoie EJ; Liu LF
    Cancer Res; 1996 Jun; 56(12):2795-800. PubMed ID: 8665516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative analysis of DNA topoisomerase I activity in human and rat glioma: characterization and mechanism of resistance to antitopoisomerase chemical, camptothecin-11.
    Matsumoto Y; Fujiwara T; Honjo Y; Sasaoka N; Tsuchida T; Nagao S
    J Surg Oncol; 1993 Jun; 53(2):97-103. PubMed ID: 8388965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA recombinase activity of eukaryotic DNA topoisomerase I; effects of camptothecin and other inhibitors.
    Pommier Y; Jenkins J; Kohlhagen G; Leteurtre F
    Mutat Res; 1995 Sep; 337(2):135-45. PubMed ID: 7565862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eukaryotic topoisomerase I-mediated cleavage requires bipartite DNA interaction. Cleavage of DNA substrates containing strand interruptions implicates a role for topoisomerase I in illegitimate recombination.
    Christiansen K; Svejstrup AB; Andersen AH; Westergaard O
    J Biol Chem; 1993 May; 268(13):9690-701. PubMed ID: 8387503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Escherichia coli DNA topoisomerase III is a site-specific DNA binding protein that binds asymmetrically to its cleavage site.
    Zhang HL; Malpure S; DiGate RJ
    J Biol Chem; 1995 Oct; 270(40):23700-5. PubMed ID: 7559540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Covalent and noncovalent DNA binding by mutants of vaccinia DNA topoisomerase I.
    Morham SG; Shuman S
    J Biol Chem; 1992 Aug; 267(22):15984-92. PubMed ID: 1322412
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of camptothecin on topoisomerase I catalysis.
    Christiansen K; Westergaard O
    Ann N Y Acad Sci; 1996 Dec; 803():50-9. PubMed ID: 8993500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATP modulates poly(ADP-ribose) polymerase-1-facilitated topoisomerase I-linked DNA religation in the presence of camptothecin.
    Park SY; Leung CH; Cheng YC
    Mol Pharmacol; 2008 Jun; 73(6):1829-37. PubMed ID: 18349103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential induction of topoisomerase I-DNA cleavage complexes by the indenoisoquinoline MJ-III-65 (NSC 706744) and camptothecin: base sequence analysis and activity against camptothecin-resistant topoisomerases I.
    Antony S; Jayaraman M; Laco G; Kohlhagen G; Kohn KW; Cushman M; Pommier Y
    Cancer Res; 2003 Nov; 63(21):7428-35. PubMed ID: 14612542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a mutant human topoisomerase I with intact catalytic activity and resistance to 9-nitro-camptothecin.
    Rubin E; Pantazis P; Bharti A; Toppmeyer D; Giovanella B; Kufe D
    J Biol Chem; 1994 Jan; 269(4):2433-9. PubMed ID: 8300570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spatial organization of topoisomerase I-mediated DNA cleavage induced by camptothecin-oligonucleotide conjugates.
    Arimondo PB; Angenault S; Halby L; Boutorine A; Schmidt F; Monneret C; Garestier T; Sun JS; Bailly C; Hélène C
    Nucleic Acids Res; 2003 Jul; 31(14):4031-40. PubMed ID: 12853620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mammalian topoisomerase I has base mismatch nicking activity.
    Yeh YC; Liu HF; Ellis CA; Lu AL
    J Biol Chem; 1994 Jun; 269(22):15498-504. PubMed ID: 8195193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CK2-mediated hyperphosphorylation of topoisomerase I targets serine 506, enhances topoisomerase I-DNA binding, and increases cellular camptothecin sensitivity.
    Bandyopadhyay K; Li P; Gjerset RA
    PLoS One; 2012; 7(11):e50427. PubMed ID: 23185622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new mechanism of acquisition of drug resistance by partial duplication of topoisomerase I.
    Komatani H; Morita M; Sakaizumi N; Fukasawa K; Yoshida E; Okura A; Yoshinari T; Nishimura S
    Cancer Res; 1999 Jun; 59(11):2701-8. PubMed ID: 10363995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage.
    Holden JA; Wall ME; Wani MC; Manikumar G
    Arch Biochem Biophys; 1999 Oct; 370(1):66-76. PubMed ID: 10496978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Camptothecin resistance from a single mutation changing glycine 363 of human DNA topoisomerase I to cysteine.
    Benedetti P; Fiorani P; Capuani L; Wang JC
    Cancer Res; 1993 Sep; 53(18):4343-8. PubMed ID: 8395982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.